ImageneBio, Inc.
IMA· Nasdaq
Released Aug 8, 2024, after the close
10-Q filed Aug 8, 2024, 39 days after period end · 0000950170-24-093880
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | — | $2.00M | $382.00K | $3.55M |
| Net Income | -$6.26M | -$17.12M | -$20.49M | -$12.68M |
| EPS Diluted | -$0.28 |
ImageneBio, Inc. · CIK 1835579 · Engraved from SEC EDGAR
| -$0.44 |
| -$0.57 |
| -$0.35 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.